CN106083998A - 一种有机碱催化巯基‑炔基反应构建多功能小分子探针的方法 - Google Patents
一种有机碱催化巯基‑炔基反应构建多功能小分子探针的方法 Download PDFInfo
- Publication number
- CN106083998A CN106083998A CN201610408155.8A CN201610408155A CN106083998A CN 106083998 A CN106083998 A CN 106083998A CN 201610408155 A CN201610408155 A CN 201610408155A CN 106083998 A CN106083998 A CN 106083998A
- Authority
- CN
- China
- Prior art keywords
- reaction
- add
- compound
- organic base
- dimethyl sulfoxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 51
- 150000007530 organic bases Chemical class 0.000 title claims abstract description 31
- 239000000523 sample Substances 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 20
- 150000003384 small molecules Chemical class 0.000 title claims abstract description 20
- 230000003197 catalytic effect Effects 0.000 title claims abstract description 13
- 125000000304 alkynyl group Chemical group 0.000 title abstract description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 54
- 150000001875 compounds Chemical class 0.000 claims description 30
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 239000012046 mixed solvent Substances 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 18
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 16
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical group CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 229940125904 compound 1 Drugs 0.000 claims description 4
- 229940125898 compound 5 Drugs 0.000 claims description 4
- -1 hexafluorophosphate Chemical compound 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 229940125782 compound 2 Drugs 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- ULWOJODHECIZAU-UHFFFAOYSA-N n,n-diethylpropan-2-amine Chemical compound CCN(CC)C(C)C ULWOJODHECIZAU-UHFFFAOYSA-N 0.000 claims description 2
- 150000003462 sulfoxides Chemical class 0.000 claims 2
- 239000012467 final product Substances 0.000 claims 1
- 239000003068 molecular probe Substances 0.000 abstract description 7
- 230000001699 photocatalysis Effects 0.000 abstract description 5
- 238000007146 photocatalysis Methods 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 239000003054 catalyst Substances 0.000 abstract description 3
- 230000007812 deficiency Effects 0.000 abstract description 3
- 230000008685 targeting Effects 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 238000003384 imaging method Methods 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000000376 reactant Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 101100073352 Streptomyces halstedii sch1 gene Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 125000001967 indiganyl group Chemical group [H][In]([H])[*] 0.000 description 5
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002603 single-photon emission computed tomography Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- AKVBCGQVQXPRLD-UHFFFAOYSA-N 2-aminooctanoic acid Chemical compound CCCCCCC(N)C(O)=O AKVBCGQVQXPRLD-UHFFFAOYSA-N 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 description 2
- 101000667110 Homo sapiens Vacuolar protein sorting-associated protein 13B Proteins 0.000 description 2
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- FVKFHMNJTHKMRX-UHFFFAOYSA-N 3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidine Chemical compound C1CCN2CCCNC2=N1 FVKFHMNJTHKMRX-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 108010025905 Cystine-Knot Miniproteins Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000002902 bimodal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000007777 multifunctional material Substances 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610408155.8A CN106083998A (zh) | 2016-06-08 | 2016-06-08 | 一种有机碱催化巯基‑炔基反应构建多功能小分子探针的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610408155.8A CN106083998A (zh) | 2016-06-08 | 2016-06-08 | 一种有机碱催化巯基‑炔基反应构建多功能小分子探针的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106083998A true CN106083998A (zh) | 2016-11-09 |
Family
ID=57228767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610408155.8A Pending CN106083998A (zh) | 2016-06-08 | 2016-06-08 | 一种有机碱催化巯基‑炔基反应构建多功能小分子探针的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106083998A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111068073A (zh) * | 2018-10-18 | 2020-04-28 | 华中师范大学 | 近红外二区荧光造影剂及其制备方法和应用 |
CN111362971A (zh) * | 2020-03-16 | 2020-07-03 | 北京师范大学 | 靶向psma的双苯并噻二唑类化合物及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060263293A1 (en) * | 2005-04-27 | 2006-11-23 | Hartmuth Kolb | Click chemistry method for synthesizing molecular imaging probes |
WO2011156686A2 (en) * | 2010-06-11 | 2011-12-15 | The Regents Of The University Of Colorado, A Body Corporate | Method for synthesizing a cyclic multivalent peptide using a thiol-mediated reaction |
CN103193867A (zh) * | 2011-12-30 | 2013-07-10 | 程震 | 一种18f-rgd多肽及其作为pet显像剂的应用 |
-
2016
- 2016-06-08 CN CN201610408155.8A patent/CN106083998A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060263293A1 (en) * | 2005-04-27 | 2006-11-23 | Hartmuth Kolb | Click chemistry method for synthesizing molecular imaging probes |
WO2011156686A2 (en) * | 2010-06-11 | 2011-12-15 | The Regents Of The University Of Colorado, A Body Corporate | Method for synthesizing a cyclic multivalent peptide using a thiol-mediated reaction |
CN103193867A (zh) * | 2011-12-30 | 2013-07-10 | 程震 | 一种18f-rgd多肽及其作为pet显像剂的应用 |
Non-Patent Citations (1)
Title |
---|
SUN YAO, ET AL.: "Strained cyclooctyne as a molecular platform for construction of multimodal imaging probes", 《ANGEW CHEM INT ED ENGL.》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111068073A (zh) * | 2018-10-18 | 2020-04-28 | 华中师范大学 | 近红外二区荧光造影剂及其制备方法和应用 |
CN111068073B (zh) * | 2018-10-18 | 2022-07-05 | 华中师范大学 | 近红外二区荧光造影剂及其制备方法和应用 |
CN111362971A (zh) * | 2020-03-16 | 2020-07-03 | 北京师范大学 | 靶向psma的双苯并噻二唑类化合物及其制备方法与应用 |
CN111362971B (zh) * | 2020-03-16 | 2021-02-09 | 北京师范大学 | 靶向psma的双苯并噻二唑类化合物及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ren et al. | Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe | |
CN110898233B (zh) | 三模态***癌靶向纳米粒子显像剂及其制备方法 | |
Liolios et al. | PET diagnostic molecules utilizing multimeric cyclic RGD peptide analogs for imaging integrin αvβ3 receptors | |
CN101991867A (zh) | 用于早期肝纤维化诊断的多模式靶向探针及其制备方法 | |
CN106083998A (zh) | 一种有机碱催化巯基‑炔基反应构建多功能小分子探针的方法 | |
Gai et al. | Universal molecular scaffold for facile construction of multivalent and multimodal imaging probes | |
Ceulemans et al. | Gadolinium (III)-DOTA complex functionalized with BODIPY as a potential bimodal contrast agent for MRI and optical imaging | |
Takakura et al. | In vitro and in vivo cell uptake of a cell-penetrating peptide conjugated with fluorescent dyes having different chemical properties | |
Cheng et al. | Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFA lin-Modified Peptidic Radioligands Targeting Both Integrin αvβ3 and the MC1 Receptor—Suitable for the Specific Visualization of Melanomas? | |
Goswami et al. | Synthesis and Relaxivity Studies of a DOTA-Based Nanomolecular Chelator Assembly Supported by an Icosahedral Closo-B122−-Core for MRI: A Click Chemistry Approach | |
CN108314678B (zh) | 以磷脂酰丝氨酸为靶点的分子探针及其用途 | |
Lundmark et al. | Design, synthesis, and evaluation of linker-optimised PSMA-targeting radioligands | |
Milot et al. | 64Cu-DOTHA2-PSMA, a novel PSMA PET radiotracer for prostate cancer with a long imaging time window | |
CN109776587A (zh) | 一种碳链延长的谷氨酰胺三氟化硼类似物 | |
CN107118767B (zh) | 一种放射性核素碘标记的荧光碳点、合成方法和应用 | |
CN106634964B (zh) | 噁嗪类化合物在制备近红外荧光探针中的应用 | |
CN105770922B (zh) | 一种64Cu标记叶酸靶向的功能化聚乙烯亚胺稳定的四氧化三锰纳米颗粒的制备方法 | |
Hübner et al. | Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye | |
CN104984371B (zh) | 一种肿瘤靶向的放射性纳米颗粒及其制备方法 | |
Li et al. | Mitochondria-targeted fluorescent nanoparticles with large stokes shift for long-term bioimaging | |
CN102070747A (zh) | 一种可用于荧光造影和同位素造影的高分子 | |
CN101912624B (zh) | 主动靶向聚合物纳米粒磁共振对比剂及其制备方法 | |
CN111317829B (zh) | 一种spect/fi双模态分子影像探针及其制备方法 | |
Hübner et al. | PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study | |
CN111253308B (zh) | 一组蛋白激酶a的小分子抑制剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170505 Address after: Jiang Xing Lu 430023 Hubei province Jianghan Jianghan District of Wuhan City Economic Development Zone No. 6 Hankou business center on the third floor of No. 1 Applicant after: Wuhan Lv Hai palm fibre bio tech ltd Address before: 430075, B1 building, Wuhan national biological industry base, 666 hi tech Avenue, East Lake Development Zone, Hubei, Wuhan Applicant before: Wuhan lvhai original biological technology Co. Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |